EGFR immmunopositive staining was observed in 2 cases (22.2%) of grade I glioma, 25 cases (44.6%) of grade II, 37 cases (71.2%) of grade III and 31 cases (88.6%) of grade IV. Here, EGFR is linked to central nervous system cancer.